These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21420426)

  • 1. Serological responses following influenza A H1N1 2009 infection in adults.
    Tan S; Gordon DL; Honda-Okubo Y; Petrovsky N; Phillips P; Huddleston S; Sadlon TA
    J Infect; 2011 May; 62(5):388-93. PubMed ID: 21420426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1.
    Zhang R; Rong X; Pan W; Peng T
    Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.
    Skowronski DM; Hottes TS; McElhaney JE; Janjua NZ; Sabaiduc S; Chan T; Gentleman B; Purych D; Gardy J; Patrick DM; Brunham RC; De Serres G; Petric M
    J Infect Dis; 2011 Jan; 203(2):158-67. PubMed ID: 21288814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying homologous and heterologous antibody titre rises after influenza virus infection.
    Freeman G; Perera RA; Ngan E; Fang VJ; Cauchemez S; Ip DK; Peiris JS; Cowling BJ
    Epidemiol Infect; 2016 Aug; 144(11):2306-16. PubMed ID: 27018720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the H1N1 influenza pandemic on the humoral immune response to seasonal flu vaccines.
    Jang H; Ross TM
    PLoS One; 2021; 16(10):e0258453. PubMed ID: 34679115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemagglutination Inhibition Antibody Response Following Influenza A(H1N1)pdm09 Virus Natural Infection: A Cross-Sectional Study from Thirthahalli, Karnataka, India.
    Alladi CSH; Jagadesh A; Prabhu SG; Arunkumar G
    Viral Immunol; 2019 Jun; 32(5):230-233. PubMed ID: 31070522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
    Narang V; Lu Y; Tan C; Camous XFN; Nyunt SZ; Carre C; Mok EWH; Wong G; Maurer-Stroh S; Abel B; Burdin N; Poidinger M; Tambyah PA; Bosco N; Visan L; Ng TP; Larbi A
    Front Immunol; 2018; 9():2465. PubMed ID: 30405641
    [No Abstract]   [Full Text] [Related]  

  • 10. Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.
    Ott U; Sauerbrei A; Lange J; Schäfler A; Walther M; Wolf G; Wutzler P; Zell R; Krumbholz A
    Med Microbiol Immunol; 2012 Aug; 201(3):297-302. PubMed ID: 22350187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.
    Agrati C; Castilletti C; Cimini E; Lapa D; Quartu S; Caglioti C; Lanini S; Cattoli G; Martini F; Ippolito G; Capobianchi MR
    PLoS One; 2014; 9(8):e105651. PubMed ID: 25162670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
    McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
    Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.
    Bragstad K; Martel CJ; Thomsen JS; Jensen KL; Nielsen LP; Aasted B; Fomsgaard A
    Influenza Other Respir Viruses; 2011 Jan; 5(1):13-23. PubMed ID: 21138536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross sectional survey of influenza antibodies before and during the 2009 pandemic in Shenzhen, China.
    Wu CL; Lu J; Wang MH; Lv X; Chen Y; Kung HF; Zee B; Cheng XW; He ML
    PLoS One; 2013; 8(1):e53847. PubMed ID: 23382854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada.
    Baz M; Papenburg J; Hamelin ME; Ouakki M; Skowronski DM; De Serres G; Boivin G
    Emerg Infect Dis; 2012 Jul; 18(7):1132-4. PubMed ID: 22710312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies.
    Stelzer-Braid S; Wong B; Robertson P; Lynch GW; Laurie K; Shaw R; Barr I; Selleck PW; Baleriola C; Escott R; Katsoulotos G; Rawlinson WD
    J Clin Virol; 2008 Oct; 43(2):241-3. PubMed ID: 18675584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological survey of antibodies to influenza A viruses in a group of people without a history of influenza vaccination.
    Chen Y; Zheng Q; Yang K; Zeng F; Lau SY; Wu WL; Huang S; Zhang J; Chen H; Xia N
    Clin Microbiol Infect; 2011 Sep; 17(9):1347-9. PubMed ID: 21749549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.